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Controlleddrugdeliverytechnologyrepresentsoneofthemostrapidlyadvancingareasofscience.Theyoﬀernumerousadvantages
compared to conventional dosage forms including improved eﬃcacy, reduced toxicity, improved patient compliance and
convenience. Over the past several decades, many delivery tools or methods were developed such as viral vector, liposome-based
delivery system, polymer-based delivery system, and intelligent delivery system. Recently, nonviral vectors, especially those based
on biodegradable polymers, have been widely investigated as vectors. Unlike the other polymers tested, polyhydroxyalkanoates
(PHAs) have been intensively investigated as a family of biodegradable and biocompatible materials for in vivo applications as
implantable tissue engineering material as well as release vectors for various drugs. On the other hand, the direct use of these
polyesters has been hampered by their hydrophobic character and some physical shortcomings, while its random copolymers
fulﬁlled the expectation of biomedical researchers by exhibiting signiﬁcant mechanical and thermal properties. This paper reviews
the strategies adapted to make functional polymer to be utilized as delivery system.
1.Introduction
For the last decades, drug delivery systems have enormously
increased their performances, moving from simple pills
to sustained/controlled release and sophisticated program-
mable delivery systems. Currently, drug delivery has also
become more speciﬁc from systemic to organ and cellular
targeting [1]. In general, the action of a drug molecule is de-
pendentonitsinherenttherapeuticactivityandtheeﬃciency
with which it is delivered to the site of action. An in-
creasing appreciation of the latter has led to the evolution
and development of novel drug delivery systems (NDDSs)
[2], whereas traditional delivery systems (TDSs) are charac-
terized by immediate and uncontrolled drug release kinetics
[3]. Accordingly, drug absorption is essentially controlled
by the body’s ability to assimilate the therapeutic molecule
and thus, drug concentration in diﬀerent body tissues,
such as the blood, typically undergoes an abrupt increase
followed by a similar decrease. As a consequence, increasing
attention has been focused on drug delivery methods which
continually delivers drugs for prolonged time periods and in
a controlled fashion. The primary method of accomplishing
this controlled release has been through incorporating the
existing drugs into new drug delivery systems such as poly-
mers. This novel approach considerably improves drug per-
formance in terms of eﬃcacy, safety and patient compliance.
A large number of both natural and synthetic polymers
have been studied for possible application in an outstanding
range of extended/controlled release properties for a wide
variety of dosage forms and processing methods. Among
the polymer tested, two promising synthetic polymers which
have been developed for biomedical applications are poly-
vinylpyrrolidone and polyethylene glycol acrylate-based
hydrogels [3]. Both of them are biodegradable and form
copolymers with natural macromolecules. On the other
hand, natural polymers have the advantage of high biocom-
patibility and less immunogenicity [4]. Among the natural
polymers studied a special mention has to be made to poly-
hydroxyalkanoates (PHAs). Other natural polymers are
chitosan, alginate, starch, pectin, casein and cellulose2 International Journal of Microbiology
Table 1: Classes of PHA synthases and varieties of P (3HA)s (adapted from Rehm 2007) [10].
Substrate speciﬁcity Class of PHA synthase Subunit(s)
(PHA synthase subunit) Microorganism Polymers produceda
SCL-3HA-CoA (C3–C5)
I PhaC Ralstonia eutropha
P( 3 H B ) ,P( 3 H B - co-3HV) III PhaC, PhaE Allochromatium
IV PhaC,PhaR vinosum
Bacillus megaterium
MCL-3HA-CoA (C6–C14)
II PhaC Pseudomonas
P( 3 H A ) oleovorans
Pseudomonas putida
Pseudomonas aeruginosa
SCL-MCL- I PhaC Aeromonas caviae
P( 3 H B - co-3HA) P (3HA)-CoA (C3–C14) II PhaC FA440
Pseudomonas sp.61-3
aP (3HB), poly-3-hydroxybutyrate, P (3HB-co-3HV), poly-3-hydroxybutyrate-co-3-hydroxyvalerate, P (3HA), poly-3-hydroxyalkanoate, P (3HB-co-3HA),
poly-3-hydroxybutyrate-co-3-hydroxyalkanoate.
derivatives. However, in recent years additional polymers
designed primarily for medical applications have entered the
arena of controlled release because of its biodegradability
within the body; among them Polylactic acid (PLA), Poly-
glycolic acid (PGA), Poly (lactic-co-glycolic acid) (PLGA),
Polycaprolactone (PCL), especially PHA (polyhydroxyalka-
noate), and PHB (polyhydroxybutyrate) have attracted
researcher’s attention. Polyhydroxyalkanoates (PHAs) are
bacterial polymers that are formed as naturally occurring
storage polyesters by a wide range of microorganisms usually
under unbalanced growth conditions. PHAs are composed
of β-hydroxy fatty acids, where the R group changes from
methyl to tridecyl. Poly (3-hydroxy butyrate) is the most
investigated PHA [5]. Initially interests on PHAs were
focused as replacements for petrochemical plastics such as
polyethylene and polypropylene, due to their degradable
nature (degradable to carbon dioxide and water through
natural microbiological mineralization), but currently due
to their biocompatibility, processability and degradability,
PHAs have been investigated as matrices for drug delivery
and tissue engineering applications [6]. Microorganisms are
able to incorporate up to 60 diﬀerent types of monomer into
their storage polymer and a series of PHAs with diﬀerent
monomeric compositions (i.e., diﬀerent physical and chem-
ical properties (Table 1)c a nb ep r o d u c e d[ 7]. Over the past
years, PHAs, particularly PHB, have been used to develop
devices including sutures, repair devices, repair patches,
slings, cardiovascular patches, orthopedic pins, adhesion
barriers, stents, guided tissue repair/regeneration devices,
articular cartilage repair devices, nerve guides, tendon repair
devices, bone marrow scaﬀolds, and wound dressings [8].
Furthermore, the in vitro and in vivo biocompatibility
experiments demonstrated that PHB can be exploited for the
purpose of encapsulation and controlled release of diﬀerent
drugs [8, 9]. Formulation performance can be optimized by
variations in molecular weights and chemical substitutions.
Each range has fundamentally diﬀerent hydrophilicity, swel-
ling and erosion characteristics which provide ﬂexibility in
controlling the release mechanisms.
2. Advantages of Using NaturalPolymer
For the past decades, polymeric materials have been used
for a variety of applications ranging from food industries,
textile and biomedical industries. Biopolymeric materials
may be utilized for the encapsulation, delivery of vari-
ous functional food ingredients, drugs such as bioactive
lipids, minerals, enzymes and peptides [11–13]. Most of
the polymers initially used for drug delivery applications
were hydrophobic and nondegradable in nature for exam-
ple, poly(dimethylsiloxane) (PS), polyurethanes (PUs) and
poly(ethylene-co-vinyl acetate) (EVA) [6]. Among the syn-
theticandnaturalpolymerstested,biopolymersaccumulated
by microbes such as Polyhydroxyalkanoates (PHAs) and
polyhydroxybutyrates (PHB) are attractive carrier matrices
for drugs where the drugs can be released by bioerosion.
At the same time, materials, which degrade or denature
soon after processing, pose a signiﬁcant threat for mass
production and industrial usage leading to limited research
interests beyond academia [12]. In order to make biopoly-
mers having broad industrial/medical relevance, it would be
bettertoformcompositebyincorporatingwithcross-linking
agents. The modiﬁcation of biopolymers with the addition
of functional groups is a common yet elegant mechanism to
createdurableandindustriallyrelevantbiopolymers.Natural
polymeric drug delivery systems have the following advan-
tages over other controlled release formulations such as good
biocompatibility, ﬂexible drug release proﬁle which could be
adjusted through the cross-linking strategies, degradability
of the by-products of the polymer and possibility of quick
elimination by the excretory system to overcome accumula-
tion in the body.
3. Biosynthesis, Structure,andProperties
of PHA
Polyhydroxyalkanoates (PHAs) are biological polyesters
accumulated by microorganisms as energy reserve materialInternational Journal of Microbiology 3
Figure 1: Phase Contrast Microscopic view of Pseudomonas sp.
LDC-5 cells with accumulated PHA granules [24].
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Figure 2: The structure of in vivo PHA inclusions and its associa-
tion with speciﬁc proteins [7].
in the form of intracellular granules. The layer of phasins
(granule associated proteins) stabilizes the granules and
prevents coalescence of granules in the cytoplasm (Figures
1 and 2). Decades of PHA research were dedicated to under-
stand the production, its material properties and potential
applications [14–17]. The mechanical property of PHA is
dependent on the side chain length of hydroxyalkanoates.
Based on that, PHAs were classiﬁed as SCL, MCL, and
LCL-PHA consisting of 3∼5, 6∼16 and >16 carbon atoms
respectively [18]( Figure 3). Unlike SCL-PHAs, MCL-PHAs
have low levels of crystallinity and are more elastic [19, 20].
Recently, reports on PHA consisting of both SCL and MCL
3-hydroxyalkanoate (3HA) monomers have demonstrated
a broader spectrum of application properties [7]. Though
many Pseudomonads belonging to rRNA-DNA homology
group I produce PHA polymers containing Medium-Length
alkyl side chains (MCL-PHA), only a few wild-type bacteria
such as Pseudomonas sp.61-3 [21], Pseudomonas oleovorans
strain B-778 [22], and Pseudomonas stutzeri [12]w e r ef o u n d
to produce a mixture of PHB and MCL-PHA. Although
some of these monomers have been found in PHA produced
by bacteria in their natural environment, a larger fraction
of monomers have been incorporated into PHA following
growth of bacteria under laboratory conditions in media
containing exotic sources of carbon. Cupriavidus neca-
tor, Rhodospirillum rubrum and Pseudomonas pseudoﬂava
are known to accumulate copolyesters composed of SCL
monomer units only, while Pseudomonas oleovorans, Pseu-
domonasputidaandotherPseudomonasstrainsbiosynthesize
copolyesters principally composed of MCL monomer units.
To a considerable extent, the substrate speciﬁcity of the
PHA synthases determines the composition of the accumu-
lated PHA. Biosynthesis of PHA is possible due to PHA
synthases exhibiting extraordinarily broad substrate ranges
[23]. Table 1 shows bacterial strains capable of producing P
(3HA) polymers, the types of polyhydroxyalkanoate (PHA)
synthases associated with those strains and the type of P
(3HA) polymers produced by those bacteria.
The size, core composition and surface functionality can
be highly controlled and provide a platform technology for
the production of functionalized, biocompatible and biode-
gradable particles, which can be applied for drug delivery,
diagnostics, bioseparation, protein immobilization and so
forth [25–27]. Thus, the value of the polymers can be in-
creased by controlling the polymer’s microstructure. The
physical properties of PHA homopolymers as well as co- and
heteropolymers have been the subject of study in various
laboratories all over the world. By controlling the monomer
composition of PHA, polymer scientists have shown that the
polymer’s physical properties can be regulated to a great ex-
tent. Furthermore, it is also clear that the rate of degradation
of PHA in various environments can be controlled by
judiciously altering its monomer composition.
4.Polymer-Based Drug DeliverySystems
In general, drug delivery systems can be classiﬁed into lipo-
somal, electromechanical and polymeric delivery systems.
Though these systems are promising, the recent focus is on
degradable polymeric matrices as drug carriers. The drugs
are incorporated in a polymer and applied to facilitate the
targeted drug delivery. The release rate depends on various
parameters like nature of the polymer matrix, matrix geom-
etry, properties of the drug, initial drug load and polymer-
drug interactions [6]. Currently biopolymers are attractive
drug carriers as these polymers need not be removed after
their function is over. Poly (3-hydroxybutyrate) was the
ﬁrst homopolymer of PHAs which are intensively used for
v a r i o u sa p p l i c a t i o n s .E a r l i e rs t u d i e sh a v er e p o r t e dt h eu s eo f
PHAs in implant biomedical devices and controlled drug-
releasecarriers[8,28,29].Inadditiontothis,therehavebeen
reports indicating that PHB and PHBV copolymer of 3-hy-
droxybutyrate (3HB) and 3-hydroxyvalerate (3HV) can be
used as extracellular controlled drug release matrices [30–
32]. Reports by Xiong et al. [33] demonstrated that lipid4 International Journal of Microbiology
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Figure 3: Chemical structure of PHA (a) and other classes (b) [10].
soluble colorant rhodamine poly (3-hydroxybutyrate-co-3-
hydroxyalkanoate) (RBITC) encapsulated in PHB and PHB-
HHX can be used for intracellular drug release. Above all,
recent development in controlled drug delivery technology
demands functionalized polymers for eﬃcient performance.
The following section will discuss the various strategies
adopted to make functionalized polymers for drug delivery.
5. Improvingthe Biopolymer for Drug Delivery
Generally, drug delivery system to be designed in such a way
is incapable of releasing its agent or agents (drugs) until
it is placed in an appropriate biological environment, since
biopolymersusedindrugdeliveryareusuallyformedoutside
of the body and impregnated with drugs before placement
the polymer plus drug complex in the body. In order to
perform this, a wide range of cross-linking strategies can be
used, including UV photopolymerization and various chem-
icalcross-linkingtechniques.Suchcross-linkingmethodsare
useful only if toxic reagents can be completely removed prior
to implantation, which may be diﬃcult to achieve without
leaching loaded drug out of the polymer complex [34].
Though these approaches are advantageous, each method
has its own advantages as well as limitations. In case of UV
cross-linking due to their deﬁned dimensionality and high
elasticityexcludestheirextrusionthroughaneedle.Butthese
can be mitigated by making the complex into micro- or
nanoparticles. Also, one has to consider the potential risks
of exposure to UV and the cross-linking chemicals [34]. In
general, the rate of drug release from a linear polymer matrix
is inversely proportional to its viscosity.
6. Surface Functionalization of
Biodegradable Polymers
Although many polymeric materials have been developed
in the past decades to improve speciﬁc properties such as
biocompatibility, degradability and drug delivery kinetics,
there are also some limitations. In order to overcome this,
copolymers with functional side groups which modify the
surface with biologically active moieties may be useful [35–
37]. Biomolecules such as ﬁbronectin [38], collagen [39],
insulin [40] and the epidermal growth factor [41]h a v e
often been introduced on polymer surfaces to enhance cell
attachment or cell proliferation. The surface modiﬁcation
can produce controlled densities of hydroxyl groups on
the surface and then these groups provide sites for the
covalent attachment of speciﬁc biomaterials such as proteins
or peptides [42]. Lee et al. [43] have performed modiﬁcationInternational Journal of Microbiology 5
of the biopolymers with various lengths of ﬂuorocarbon (F-
polyesters) end groups; this may improve the controllable
biodegradability at initial stages by controlling the surface
composition of ﬂuorocarbon groups. Kang et al. [44, 45]
emphasized the importance of plasma glow discharge tech-
nique in which partially ionized gas consisting of equal num-
bers of positive and negative charges and a diﬀerent num-
ber of unionized neutral molecules is subjected to a DC or
radio frequency (RF) potential. In order to introduce func-
tional groups to polymeric surfaces (surface modiﬁcation),
glow discharge is widely used at reduced pressure. The char-
acteristic glow of these plasmas is due to electronically ex-
cited species producing optical emission in the ultraviolet or
visible regions of the spectrum and is characteristic of the
composition of the glow discharge gas. Argon gives a bright
blue colour and air or nitrogen gives a pink color that is due
to excited nitrogen molecules.
7.Cross-LinkingStrategies
In order to increase the stability, there is a growing trend to-
wards the development of innovative biopolymeric material
through the rational design of functional structures by cross-
linking using various physical, chemical and enzymatic ap-
proaches depending on the speciﬁc characteristics of the bio-
polymers involved, rather than the use of the more tradi-
tional trial and error approach. These crosslinked polymers
exhibit the required functional attributes, for example, opti-
cal properties, rheological properties, release characteristics,
encapsulation properties and physicochemical stability [11].
8.Cross-LinkingthroughPhysicalMethods
Polymer-polymer interaction without covalent bonding is
known as physical cross-linking [46]. This includes ionic
cross-linking, hydrogen bonding and hydrophobic bonding.
Physicalcross-linkingcanbeachievedusingavarietyofenvi-
ronmental triggers such as pH, temperature, ionic strength
andphysiochemicalinteractionssuchashydrophobic,charge
condensation, hydrogen bonding and stereocomplexation
[34]. These methods may be used for the induction of gela-
tion processes among already formed discrete biopolymer
particles.
9. Temperature
Temperature either strengthens or weakens the interactions
of holding biopolymer molecules together, depending on
the nature of the dominant forces involved. In general,
hydrophobicforcesarestrengthenedwithincreasingtemper-
ature,hydrogenbondingisweakened,andentropyeﬀectsare
increased. Heating (heat-set-gelation) increases the hydro-
phobic driven association and cooling (cold-set-gelation)
increases hydrogen bonding-driven association [47]. These
temperature-associated reactions are either reversible or
irreversible. Heat-set-gelation is used to cross-link globular
proteins, such as milk, soy and egg as well as cross-link
polysaccharides with some hydrophobic character. Cross-
linking using heat-set-gelation of globular proteins tends
to be irreversible. Once the aggregates are formed at high-
er temperatures, they remain intact when the system is
cooled below the thermal denaturation temperature. In this
reaction, the system is cooled below the thermal aggregation
temperature as the molecules tend to dissociate [48]. Cold-
set-gelation is stable at relatively low temperatures, but it
tends to dissociate when heated above a critical temperature.
This kind of gelation involves those biopolymers that are
capable of forming helical regions that associate with each
other through hydrogen bonding upon cooling. In case of
mixed biopolymer systems that segregate, decreased temper-
atures can be utilized to favor separation, which in turn
increases the biopolymer interaction within the dispersed
phase [49]. Increased biopolymer interactions within these
excludedvolumesresultedintogel-likematrices;furtherhea-
ting may be utilized to further solidify these compact phases
into particulates [50].
10. pH
Ingeneral,theresponse indiﬀerentregions ofthebody is de-
pendent on pH; the release of drugs in controlled fashion is
possible by modifying the polymer cross-linking. Changes in
pH and addition of mineral ions may be used to promote
biopolymer association through alterations in electrostatic
interactions.Forexample,calciumions(Ca2+)ar efr equently
used to cross-link anionic polysaccharides such as pectins,
alginates, or carrageenans [51]. Potassium ions (K+)a r eu s e d
to cross-link anionic carrageenans through the formation of
an “egg-box” structure [51]. Addition of mineral ion may be
used to cross-link biopolymer particles in various ways [52].
An alternative method is to utilize slow-releasing salt devices
to initiate cross-linking for controlled release of drug.
11. Chemical Cross-Linking
Introduction of a covalent linkage between polymer func-
tional group is known as chemical cross-linking. The chem-
ical agents may act as a bridge between similar or dissimilar
amino acids [53]. They may also be used to directly bond 2
amino acids together. Functional groups capable of chemical
bonds include amines, thiols, hydroxyl groups and phenyl
rings. These chemical cross-linking strategies are widely used
by researchers all over the world in comparison to physical
cross-linking of functional groups in biopolymer.
12. Amphiphilic PHAs
PHAs are promising materials for biomedical applications in
tissue engineering and drug delivery system because of their
properties such as natural, renewable, biodegradable and
biocompatible thermoplastics. The key to biocompatibility
of biomedical implantable materials is to render their surface
in a way that minimizes hydrophobic interaction with the
surrounding tissue. Therefore, hydrophilic groups need to
be introduced into the PHAs in order to obtain amphiphilic6 International Journal of Microbiology
polymer. Amphiphilic polymers can be synthesized by intro-
ducinghydrophilicgroupssuchashydroxyl,carboxyl,amine,
glycol and hydrophilic polymers such as PEG, poly(vinyl
alcohol), polyacryl amide, poly acrylic acids, hydroxy ethyl
methacrylate, poly vinyl pyridine and poly vinyl pyrrolidone
to a hydrophobic moiety by means of functionalization and
grafting [54]. Among the hydrophilic groups, PEG is a poly-
ether known for its exceptional blood and tissue compatibil-
ity. It is used extensively as biomaterial in a variety of drug
delivery vehicles and is also under investigation as surface
coating for biomedical implants. PEG, when dissolved in
water, has a low interfacial free energy and exhibits rapid
chain motion and its large excluded volume leads to steric
repulsion of approaching molecules [55].
13. Transesteriﬁcation
Under certain conditions, esters and amides are capa-
ble of undergoing interchange reactions in aqueous solu-
tions. Transesteriﬁcation is carried out either in melt
or in solution. Transesteriﬁcation reactions in the melt
betweenpoly(ethyleneglycol),mPEG,andPHByielddiblock
amphiphilic copolymer with a dramatic decrease in molecu-
lar weight [56]. Genipin is a naturally occurring heterocyclic
compound derived from Genipa americana that is able to
form physical links between biopolymers containing amines.
Mi et al. [57] reported that the primary amine groups
located on biopolymers attack at either the α-o rβ-carbon
of the genipin ester. During the attachment at the α-carbon
that forms a simple amide linkage, attack at the β-carbon
causes ring cleavage and further cross-linking capability.
So far the genipin crosslinked biopolymers are chitosan,
BSA, soy protein and gelatin [58]. Furthermore, the natural
compound genipin is considered to be less cytotoxic than
other cross-linking agents such as glutaraldehyde [57].
14. Maillard Reactions
Biopolymers are capable of loading both hydrophilic and hy-
drophobic drugs; in particular, modiﬁed polymers without
synthetic chemical reagents are obviously desirable for bio-
medical applications. Several groups have studied the poly-
mer fabrications for controlled release applications. One
such fabrication is Maillard reaction; Maillard reaction is a
natural, nontoxic reaction that occurs during the processing,
cooking and storage of foods. As per, Oliver et al. [59], Mail-
lard reaction is chemical linking of aldehydes and amines
through a well-established oxidation-reduction pathway.
High pH values favored these imido- and redox reactions.
Maillarad conjugates have been used as emulsiﬁers and gell-
ingagents.Forexample,theconjugationofhenegglysozyme
with dextran, galactomannan, or xyloglucan is eﬀective in
improving the emulsifying activity of the protein and it has
been shown that the conjugated lysozyme has new anti-
microbialcharacteristics[60,61].RichandFoegeding(2000)
[62] demonstrated that these Maillard reactions are useful
to cross-link protein components with mono- and disaccha-
rides. Recent, reports by Elzoghby et al. [63] have shown the
signiﬁcance of casein-based formulations as promising con-
trolled release drug delivery systems. Casein, the major milk
protein, is a good candidate for conventional and novel drug
delivery systems for its property with high tensile strength.
This Maillard reaction could also be used to cross-link pro-
teins and polysaccharides within the biopolymer particles
formed by spray-or freeze-drying. After drying, the system
canthenbesubjectedtodry-heatingtopromotetheMaillard
reaction.
15. Aldehyde Reactions
Glutaraldehyde and formaldehyde can be used to chemically
cross-link protein particulate system. These may form com-
pounds such as acetals, cyanohydrins, and oximes [64]. At
the same time, studies by [65] showed that even 3ppm of
nonfood grade aldehydes exhibits cytotoxic eﬀects to human
ﬁbroblasts. As a result, attempts were put forth to identify a
number of food-grade alternatives to replace the potentially
toxic compounds.
16. Quaternizationand Sulfonation
of the PHAs
Addition of the chlorine and bromine into the double bond
is quantitative and halogenated PHAs can be easily obtained
bythisapproach[66].Chlorinationcanbedonebyeitherthe
addition to double bonds of the unsaturated PHA obtained
from soybean oil (PHA-Sy) or substitution reactions with
saturated hydrocarbon groups [67, 68]. Chlorination pro-
vides polyester with hard, brittle and crystalline physical
properties depending on the chlorine content and also glass
transition temperature has been shifted from −40◦Ct o+ 2 ◦C
[68]. For further functionalization, quaternization reactions
of the chlorinated PHA with triethylamine (or triethanol
amine) can be performed.
17.Enzymatic Methods
Apartfromphysicalandchemicalcross-linking,enzymescan
also be utilized to catalyze speciﬁc cross-linking reactions
betweenpolymer.Theyareparticularlyusefulinapplications
where alternative methods might cause damage to some
encapsulated component. At the same time, sulfhydryl or
phenolic residues can be oxidatively cross-linked using high
levels of gaseous oxygen, but this would be deleterious to
high-value lipids or phenolics [69]. In this case, usage of
speciﬁc enzymes is a very good alternative. Recent reports on
laccases (benzenediol: oxygen oxidoreductases; EC 1.10.3.2.)
which are glycosylated polyphenol oxidases containing four
copper ions per molecule, produced by white rot fungi in
large amounts, have widespread applications such as eﬄuent
decolouration pulp bleaching and removal of phenolics
from wines, organic synthesis, biosensors and synthesis of
complex medical compounds, among others. Laccases are
also able to cross-link biopolymers containing phenolic acids
like ferulated arabinoxylans [70–72]. In particular, recently,
enzymaticcross-linkingandgraftingofspeciﬁcsubstancestoInternational Journal of Microbiology 7
thebiopolymers canbeexploitedinfoodandnonfoodappli-
cations allowing for generation of novel biomaterials [73].
De Jong and Koppelman [74] have reported the importance
of transglutaminase which is commonly produced from
bacterial sources that can be used as cross-linking agents for
various types of proteins. This enzyme functions by a non-
oxidative transamidation between glutamine and lysine,
whether intra- or intermolecularly. Transglutaminase has
been used to produce crosslinked protein ﬁlms from gelatin
[75], egg-white [76], gluten [77], soybean and whey proteins
[78].Theextentofcross-linkingcanbecontrolledbychanges
in pH, enzyme inhibitors, or heating [74].
18.Grafting
Some of the naturally occurring polymers such as polyhy-
droxyalkanoate, alginate and chitosan ﬁnd increasing appli-
cation in biomedical research due to their biocompatible,
biodegradable and nontoxic properties. However, to over-
come the limitations posed by these polymers such as low
moisture resistance, poor processability and incompatibility
with some hydrophobic functional groups, the eﬀective
modiﬁcation method grafting is adopted. This method is
used to prepare multifunctional materials with improved
chemical, physical and mechanical properties. Chitosan,
sugar,PLA,gelatin,andPEG-mediatedgraftingarediscussed
in several studies [79–82]. Among these, glycopolymers are
emerging as a novel class of neoglycoconjugates useful for
biological studies and they are prepared by either copoly-
merization or grafting methods. One another, recently noted
hydrophobic polymer with biodegradable ketal linkages in
its backbone has an advantage over current biodegradable
polymers for drug delivery is Polyketals. Polyketals do
not release inﬂammatory byproducts compared to existing
polymers [82].
19. Conclusion
Presently, novel polymeric materials have revolutionized
the polymer applications in various ﬁelds including phar-
maceutical, food and agricultural applications, pesticides,
cosmetics, and household products. Particularly, in the phar-
maceutical ﬁeld, in addition to the importance of polymers,
an understanding of the physiological barriers in the human
body is also critical to develop appropriate controlled release
systems. The skin, the gastrointestinal tract, the nose and the
eye are of particular importance. In the immediate future,
one of the dominant factors to be expected from human
endeavor is environmental friendliness. Along this line,
serious eﬀorts are mounted to the developments of biopoly-
mers with appropriate properties and processability, the so-
called “green” polymers, that contrast to the conventional
petrochemically originated polymers. In the future, custom-
made prominent MCL-PHA synthases generated through
Pseudomonas enzyme evolution will be utilized extensively
to create high-performance P (3HA)s in various organisms
from renewable carbon sources or through improved in vitro
systems.
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